Non Permanent Atrial Fibrillation clinical trials

Explore recruiting non permanent atrial fibrillation clinical trials.

Recruiting non permanent atrial fibrillation studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Permanent Atrial Fibrillation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-Label, Dose Escalation Study of the Safety, Tolerability, and Efficacy of Budiodarone for the Treatment of Subjects with Non-permanent Atrial Fibrillation

Poland

Phase II and Phase III (Integrated) EU CTIS Study details

Non Permanent Atrial Fibrillation trials by city

Non Permanent Atrial Fibrillation in Toronto Non Permanent Atrial Fibrillation in Vancouver Non Permanent Atrial Fibrillation in Montreal Non Permanent Atrial Fibrillation in Calgary Non Permanent Atrial Fibrillation in Edmonton Non Permanent Atrial Fibrillation in Ottawa Non Permanent Atrial Fibrillation in Winnipeg Non Permanent Atrial Fibrillation in Quebec City Non Permanent Atrial Fibrillation in Hamilton Non Permanent Atrial Fibrillation in Kitchener Non Permanent Atrial Fibrillation in London Non Permanent Atrial Fibrillation in Halifax Non Permanent Atrial Fibrillation in New York Non Permanent Atrial Fibrillation in Los Angeles Non Permanent Atrial Fibrillation in Chicago Non Permanent Atrial Fibrillation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease